CSF2 and tuberculosis: In our proof-of-concept studies, we show that this albumin-fusion strategy (albGM-CSF) enhances the serum levels of GM-CSF, leading to increased DC populations, cytokine secretion, and CD4+ T-cell activation, thus improving the control of chronic TB in mice.